Mediplantex National Pharmaceutical JSC (HNX:MED)
20,400
0.00 (0.00%)
At close: Mar 31, 2026
HNX:MED Market Cap
HNX:MED has a market cap or net worth of 253.16 billion as of April 7, 2026. Its market cap has increased by 55.05% in one year.
Market Cap
253.16B
Enterprise Value
255.98B
Revenue
366.83B
Ranking
n/a
PE Ratio
15.99
Stock Price
20,400.00
Market Cap Chart
Since March 18, 2020, HNX:MED's market cap has decreased from 307.72B to 253.16B, a decrease of -17.73%. That is a compound annual growth rate of -3.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 253.16B | -13.19% |
| Dec 31, 2025 | 291.64B | -12.96% |
| Dec 27, 2023 | 335.07B | 28.57% |
| Dec 26, 2022 | 260.61B | 38.79% |
| Dec 31, 2021 | 187.77B | -23.33% |
| Dec 24, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OPC Pharmaceutical JSC | 1.41T |
| Pharmedic Pharmaceutical Medicinal JSC | 1.35T |
| Vidipha Central Pharmaceutical JSC | 1.33T |
| Central Pharmaceutical Joint Stock Company No3 | 1.19T |
| Ben Tre Pharmaceutical JSC | 237.25B |
| American Vietnamese Biotech Incorporation | 235.99B |
| Vimedimex Medi-Pharma JSC | 233.15B |
| Phong Phu Pharmaceutical JSC | 159.28B |